Clinical Trials

Showing trials with last updates posted in 2026.

NCT06469944 | RECRUITING | PHASE1/PHASE2
160 participants

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2024-09-20
Completion:
2029-09-12
Conditions
  • Gastroesophageal Junction
  • Gastroesophageal Adenocarcinoma
  • Esophageal Neoplasms
  • Esophageal Cancer
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT06370520 | RECRUITING
2592 participants

Screening Emotions in Adolescents at the Hospital for mTBI

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-02
Start Date:
2024-05-22
Completion:
2028-09-30
Conditions
  • Brain Injury Traumatic Mild
  • Brain Injuries
  • Brain Injuries, Acute
  • Head Injury With Intracranial Hemorrhage
  • Head Injury Trauma
  • Brain Injury Traumatic Focal With Loss of Consciousness
  • Skull Fractures
  • Diffuse Axonal Injury
  • Intracranial Hemorrhages
  • Head Injury
Interventions
  • BEHAVIORAL
  • OTHER
No Results Yet
NCT06317662 | RECRUITING | PHASE2
153 participants

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2025-06-05
Completion:
2028-12-31
Conditions
  • Acute Leukemia of Ambiguous Lineage
  • B Acute Lymphoblastic Leukemia
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT06251310 | RECRUITING | PHASE1
186 participants

SW-682 in Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2024-07-31
Completion:
2027-01-18
Conditions
  • Advanced Solid Tumor
  • Mesothelioma, Malignant
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page